dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with adenosine monophosphate in 1 studies
| Studies (dibutyryl cyclic-3',5'-cytidine monophosphate) | Trials (dibutyryl cyclic-3',5'-cytidine monophosphate) | Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate) | Studies (adenosine monophosphate) | Trials (adenosine monophosphate) | Recent Studies (post-2010) (adenosine monophosphate) |
|---|---|---|---|---|---|
| 72 | 0 | 18 | 11,432 | 257 | 2,798 |
| Protein | Taxonomy | dibutyryl cyclic-3',5'-cytidine monophosphate (IC50) | adenosine monophosphate (IC50) |
|---|---|---|---|
| Fructose-1,6-bisphosphatase 1 | Sus scrofa (pig) | 1.3 | |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 2.6436 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.6 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.1 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.44 | |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, M; Lecchi, A | 1 |
1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and adenosine monophosphate
| Article | Year |
|---|---|
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Blood Platelets; Cyclic AMP; Cyclic CMP; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Thrombin | 2007 |